Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
CALL
PTC Therapeutics
PTCT
$5.68B
| $779K | ﹤0.01% |
+21,000
| New | +$703K |
|
|
3427
PUT
PTC Therapeutics
PTCT
$5.68B
| $779K | ﹤0.01% |
+21,000
| New | +$703K |
|
|
KALV
3428
DELISTED
KalVista Pharmaceuticals
KALV
| $778K | ﹤0.01% |
67,222
+54,257
| +418% | +$682K |
|
3429
1-800-Flowers.com
FLWS
$250M
| $776K | ﹤0.01% |
97,904
+19,150
| +24% | +$170K |
|
3430
Digital Turbine
APPS
$975M
| $776K | ﹤0.01% |
252,673
+97,196
| +63% | +$262K |
|
3431
Clearwater Paper
CLW
$339M
| $775K | ﹤0.01% |
27,139
+20,966
| +340% | +$818K |
|
3432
Vestis
VSTS
$1.91B
| $775K | ﹤0.01% |
51,981
+42,450
| +445% | +$570K |
|
|
DFTX
3433
Definium Therapeutics
DFTX
$5.78B
| $774K | ﹤0.01% |
136,098
+91,271
| +204% | +$635K |
|
|
ORC
3434
Orchid Island Capital
ORC
$1.3B
| $773K | ﹤0.01% |
94,005
+75,557
| +410% | +$623K |
|
|
SEZL
3435
Sezzle
SEZL
$5.2B
| $770K | ﹤0.01% |
27,090
+15,072
| +125% | +$293K |
|
3436
Manitowoc
MTW
$497M
| $769K | ﹤0.01% |
79,896
-5,771
| -7% | -$60.2K |
|
3437
Ibotta
IBTA
$559M
| $766K | ﹤0.01% |
12,437
+9,854
| +381% | +$596K |
|
3438
Regional Management Corp
RM
$301M
| $766K | ﹤0.01% |
23,416
+9,910
| +73% | +$307K |
|
|
PKST
3439
DELISTED
Peakstone Realty Trust
PKST
| $764K | ﹤0.01% |
56,078
+42,681
| +319% | +$559K |
|
|
CHCT
3440
Community Healthcare Trust
CHCT
$523M
| $763K | ﹤0.01% |
42,054
+25,826
| +159% | +$528K |
|
|
CVGW
3441
DELISTED
Calavo Growers
CVGW
| $760K | ﹤0.01% |
26,625
+20,551
| +338% | +$502K |
|
3442
UroGen Pharma
URGN
$1.86B
| $759K | ﹤0.01% |
59,778
+48,040
| +409% | +$713K |
|
|
LAZR
3443
DELISTED
Luminar Technologies
LAZR
| $758K | ﹤0.01% |
56,153
+46,288
| +469% | +$840K |
|
3444
Ero Copper
ERO
$2.81B
| $757K | ﹤0.01% |
33,987
+13,309
| +64% | +$272K |
|
|
FFIC
3445
DELISTED
Flushing Financial
FFIC
| $756K | ﹤0.01% |
51,833
+18,773
| +57% | +$264K |
|
3446
nLIGHT
LASR
$3.88B
| $755K | ﹤0.01% |
70,599
+53,699
| +318% | +$607K |
|
3447
Daktronics
DAKT
$955M
| $754K | ﹤0.01% |
58,388
+45,360
| +348% | +$627K |
|
3448
Mitsubishi UFJ Financial
MUFG
$253B
| $752K | ﹤0.01% |
+73,897
| New | +$780K |
|
|
DHIL
3449
DELISTED
Diamond Hill
DHIL
| $752K | ﹤0.01% |
4,654
+3,429
| +280% | +$527K |
|
|
CMA
3450
PUT
DELISTED
Comerica
CMA
| $749K | ﹤0.01% |
+12,500
| New | +$689K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.